Table of Content

1 Oral Medicines for Diabetes Market Overview
1.1 Product Overview and Scope of Oral Medicines for Diabetes
1.2 Oral Medicines for Diabetes Segment by Type
1.2.1 Global Oral Medicines for Diabetes Market Value Comparison by Type (2024-2034)
1.2.2 Biguanides
1.2.3 Sulfonylureas
1.2.4 Meglitinides
1.2.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
1.2.6 SGLT2 Inhibitors
1.2.7 Thiazolidinediones
1.2.8 Alpha-Glucosidase Inhibitors
1.2.9 Other
1.3 Oral Medicines for Diabetes Segment by Application
1.3.1 Global Oral Medicines for Diabetes Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Oral Medicines for Diabetes Market Size Estimates and Forecasts
1.4.1 Global Oral Medicines for Diabetes Revenue 2024-2034
1.4.2 Global Oral Medicines for Diabetes Sales 2024-2034
1.4.3 Global Oral Medicines for Diabetes Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Oral Medicines for Diabetes Market Competition by Manufacturers
2.1 Global Oral Medicines for Diabetes Sales Market Share by Manufacturers (2024-2024)
2.2 Global Oral Medicines for Diabetes Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Oral Medicines for Diabetes Average Price by Manufacturers (2024-2024)
2.4 Global Oral Medicines for Diabetes Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Oral Medicines for Diabetes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Medicines for Diabetes, Product Type & Application
2.7 Oral Medicines for Diabetes Market Competitive Situation and Trends
2.7.1 Oral Medicines for Diabetes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Medicines for Diabetes Players Market Share by Revenue
2.7.3 Global Oral Medicines for Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Medicines for Diabetes Retrospective Market Scenario by Region
3.1 Global Oral Medicines for Diabetes Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Oral Medicines for Diabetes Global Oral Medicines for Diabetes Sales by Region: 2024-2034
3.2.1 Global Oral Medicines for Diabetes Sales by Region: 2024-2024
3.2.2 Global Oral Medicines for Diabetes Sales by Region: 2024-2034
3.3 Global Oral Medicines for Diabetes Global Oral Medicines for Diabetes Revenue by Region: 2024-2034
3.3.1 Global Oral Medicines for Diabetes Revenue by Region: 2024-2024
3.3.2 Global Oral Medicines for Diabetes Revenue by Region: 2024-2034
3.4 North America Oral Medicines for Diabetes Market Facts & Figures by Country
3.4.1 North America Oral Medicines for Diabetes Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Oral Medicines for Diabetes Sales by Country (2024-2034)
3.4.3 North America Oral Medicines for Diabetes Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Medicines for Diabetes Market Facts & Figures by Country
3.5.1 Europe Oral Medicines for Diabetes Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Oral Medicines for Diabetes Sales by Country (2024-2034)
3.5.3 Europe Oral Medicines for Diabetes Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Medicines for Diabetes Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Medicines for Diabetes Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Oral Medicines for Diabetes Sales by Country (2024-2034)
3.6.3 Asia Pacific Oral Medicines for Diabetes Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Medicines for Diabetes Market Facts & Figures by Country
3.7.1 Latin America Oral Medicines for Diabetes Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Oral Medicines for Diabetes Sales by Country (2024-2034)
3.7.3 Latin America Oral Medicines for Diabetes Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Medicines for Diabetes Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Medicines for Diabetes Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Oral Medicines for Diabetes Sales by Country (2024-2034)
3.8.3 Middle East and Africa Oral Medicines for Diabetes Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Medicines for Diabetes Sales by Type (2024-2034)
4.1.1 Global Oral Medicines for Diabetes Sales by Type (2024-2024)
4.1.2 Global Oral Medicines for Diabetes Sales by Type (2024-2034)
4.1.3 Global Oral Medicines for Diabetes Sales Market Share by Type (2024-2034)
4.2 Global Oral Medicines for Diabetes Revenue by Type (2024-2034)
4.2.1 Global Oral Medicines for Diabetes Revenue by Type (2024-2024)
4.2.2 Global Oral Medicines for Diabetes Revenue by Type (2024-2034)
4.2.3 Global Oral Medicines for Diabetes Revenue Market Share by Type (2024-2034)
4.3 Global Oral Medicines for Diabetes Price by Type (2024-2034)
5 Segment by Application
5.1 Global Oral Medicines for Diabetes Sales by Application (2024-2034)
5.1.1 Global Oral Medicines for Diabetes Sales by Application (2024-2024)
5.1.2 Global Oral Medicines for Diabetes Sales by Application (2024-2034)
5.1.3 Global Oral Medicines for Diabetes Sales Market Share by Application (2024-2034)
5.2 Global Oral Medicines for Diabetes Revenue by Application (2024-2034)
5.2.1 Global Oral Medicines for Diabetes Revenue by Application (2024-2024)
5.2.2 Global Oral Medicines for Diabetes Revenue by Application (2024-2034)
5.2.3 Global Oral Medicines for Diabetes Revenue Market Share by Application (2024-2034)
5.3 Global Oral Medicines for Diabetes Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Bayer Oral Medicines for Diabetes Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Merck Oral Medicines for Diabetes Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Novartis Oral Medicines for Diabetes Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Huadong Medicine
6.4.1 Huadong Medicine Corporation Information
6.4.2 Huadong Medicine Description and Business Overview
6.4.3 Huadong Medicine Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Huadong Medicine Oral Medicines for Diabetes Product Portfolio
6.4.5 Huadong Medicine Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Sanofi Oral Medicines for Diabetes Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Novo Nordisk Oral Medicines for Diabetes Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Servier
6.6.1 Servier Corporation Information
6.6.2 Servier Description and Business Overview
6.6.3 Servier Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Servier Oral Medicines for Diabetes Product Portfolio
6.7.5 Servier Recent Developments/Updates
6.8 Takeda Pharmaceutical
6.8.1 Takeda Pharmaceutical Corporation Information
6.8.2 Takeda Pharmaceutical Description and Business Overview
6.8.3 Takeda Pharmaceutical Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Takeda Pharmaceutical Oral Medicines for Diabetes Product Portfolio
6.8.5 Takeda Pharmaceutical Recent Developments/Updates
6.9 Luye Pharmaceutical
6.9.1 Luye Pharmaceutical Corporation Information
6.9.2 Luye Pharmaceutical Description and Business Overview
6.9.3 Luye Pharmaceutical Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Luye Pharmaceutical Oral Medicines for Diabetes Product Portfolio
6.9.5 Luye Pharmaceutical Recent Developments/Updates
6.10 Taiji Group
6.10.1 Taiji Group Corporation Information
6.10.2 Taiji Group Description and Business Overview
6.10.3 Taiji Group Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Taiji Group Oral Medicines for Diabetes Product Portfolio
6.10.5 Taiji Group Recent Developments/Updates
6.11 CR Double-Crane
6.11.1 CR Double-Crane Corporation Information
6.11.2 CR Double-Crane Oral Medicines for Diabetes Description and Business Overview
6.11.3 CR Double-Crane Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.11.4 CR Double-Crane Oral Medicines for Diabetes Product Portfolio
6.11.5 CR Double-Crane Recent Developments/Updates
6.12 AstraZeneca
6.12.1 AstraZeneca Corporation Information
6.12.2 AstraZeneca Oral Medicines for Diabetes Description and Business Overview
6.12.3 AstraZeneca Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.12.4 AstraZeneca Oral Medicines for Diabetes Product Portfolio
6.12.5 AstraZeneca Recent Developments/Updates
6.13 Boehringer Ingelheim
6.13.1 Boehringer Ingelheim Corporation Information
6.13.2 Boehringer Ingelheim Oral Medicines for Diabetes Description and Business Overview
6.13.3 Boehringer Ingelheim Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Boehringer Ingelheim Oral Medicines for Diabetes Product Portfolio
6.13.5 Boehringer Ingelheim Recent Developments/Updates
6.14 Qilu Pharmaceutical
6.14.1 Qilu Pharmaceutical Corporation Information
6.14.2 Qilu Pharmaceutical Oral Medicines for Diabetes Description and Business Overview
6.14.3 Qilu Pharmaceutical Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Qilu Pharmaceutical Oral Medicines for Diabetes Product Portfolio
6.14.5 Qilu Pharmaceutical Recent Developments/Updates
6.15 Jiangsu Deyuan Pharmaceutical
6.15.1 Jiangsu Deyuan Pharmaceutical Corporation Information
6.15.2 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Description and Business Overview
6.15.3 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Product Portfolio
6.15.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
6.16 CTTQ
6.16.1 CTTQ Corporation Information
6.16.2 CTTQ Oral Medicines for Diabetes Description and Business Overview
6.16.3 CTTQ Oral Medicines for Diabetes Sales, Revenue and Gross Margin (2024-2024)
6.16.4 CTTQ Oral Medicines for Diabetes Product Portfolio
6.16.5 CTTQ Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Medicines for Diabetes Industry Chain Analysis
7.2 Oral Medicines for Diabetes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Medicines for Diabetes Production Mode & Process
7.4 Oral Medicines for Diabetes Sales and Marketing
7.4.1 Oral Medicines for Diabetes Sales Channels
7.4.2 Oral Medicines for Diabetes Distributors
7.5 Oral Medicines for Diabetes Customers
8 Oral Medicines for Diabetes Market Dynamics
8.1 Oral Medicines for Diabetes Industry Trends
8.2 Oral Medicines for Diabetes Market Drivers
8.3 Oral Medicines for Diabetes Market Challenges
8.4 Oral Medicines for Diabetes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Medicines for Diabetes Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Oral Medicines for Diabetes Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Oral Medicines for Diabetes Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oral Medicines for Diabetes Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Oral Medicines for Diabetes Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Oral Medicines for Diabetes Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Oral Medicines for Diabetes Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Oral Medicines for Diabetes Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Oral Medicines for Diabetes, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Oral Medicines for Diabetes, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Medicines for Diabetes, Product Type & Application
Table 12. Global Key Manufacturers of Oral Medicines for Diabetes, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Medicines for Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Medicines for Diabetes as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Medicines for Diabetes Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Oral Medicines for Diabetes Sales by Region (2024-2024) & (K Units)
Table 18. Global Oral Medicines for Diabetes Sales Market Share by Region (2024-2024)
Table 19. Global Oral Medicines for Diabetes Sales by Region (2024-2034) & (K Units)
Table 20. Global Oral Medicines for Diabetes Sales Market Share by Region (2024-2034)
Table 21. Global Oral Medicines for Diabetes Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Oral Medicines for Diabetes Revenue Market Share by Region (2024-2024)
Table 23. Global Oral Medicines for Diabetes Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Oral Medicines for Diabetes Revenue Market Share by Region (2024-2034)
Table 25. North America Oral Medicines for Diabetes Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Oral Medicines for Diabetes Sales by Country (2024-2024) & (K Units)
Table 27. North America Oral Medicines for Diabetes Sales by Country (2024-2034) & (K Units)
Table 28. North America Oral Medicines for Diabetes Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Oral Medicines for Diabetes Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Oral Medicines for Diabetes Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Oral Medicines for Diabetes Sales by Country (2024-2024) & (K Units)
Table 32. Europe Oral Medicines for Diabetes Sales by Country (2024-2034) & (K Units)
Table 33. Europe Oral Medicines for Diabetes Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Oral Medicines for Diabetes Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Oral Medicines for Diabetes Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Oral Medicines for Diabetes Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Oral Medicines for Diabetes Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Oral Medicines for Diabetes Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Oral Medicines for Diabetes Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Oral Medicines for Diabetes Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Oral Medicines for Diabetes Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Oral Medicines for Diabetes Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Oral Medicines for Diabetes Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Oral Medicines for Diabetes Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Oral Medicines for Diabetes Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Oral Medicines for Diabetes Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Oral Medicines for Diabetes Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Oral Medicines for Diabetes Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Medicines for Diabetes Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Oral Medicines for Diabetes Sales (K Units) by Type (2024-2024)
Table 51. Global Oral Medicines for Diabetes Sales (K Units) by Type (2024-2034)
Table 52. Global Oral Medicines for Diabetes Sales Market Share by Type (2024-2024)
Table 53. Global Oral Medicines for Diabetes Sales Market Share by Type (2024-2034)
Table 54. Global Oral Medicines for Diabetes Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Oral Medicines for Diabetes Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Oral Medicines for Diabetes Revenue Market Share by Type (2024-2024)
Table 57. Global Oral Medicines for Diabetes Revenue Market Share by Type (2024-2034)
Table 58. Global Oral Medicines for Diabetes Price (US$/Unit) by Type (2024-2024)
Table 59. Global Oral Medicines for Diabetes Price (US$/Unit) by Type (2024-2034)
Table 60. Global Oral Medicines for Diabetes Sales (K Units) by Application (2024-2024)
Table 61. Global Oral Medicines for Diabetes Sales (K Units) by Application (2024-2034)
Table 62. Global Oral Medicines for Diabetes Sales Market Share by Application (2024-2024)
Table 63. Global Oral Medicines for Diabetes Sales Market Share by Application (2024-2034)
Table 64. Global Oral Medicines for Diabetes Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Oral Medicines for Diabetes Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Oral Medicines for Diabetes Revenue Market Share by Application (2024-2024)
Table 67. Global Oral Medicines for Diabetes Revenue Market Share by Application (2024-2034)
Table 68. Global Oral Medicines for Diabetes Price (US$/Unit) by Application (2024-2024)
Table 69. Global Oral Medicines for Diabetes Price (US$/Unit) by Application (2024-2034)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Bayer Oral Medicines for Diabetes Product
Table 74. Bayer Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Merck Oral Medicines for Diabetes Product
Table 79. Merck Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Novartis Oral Medicines for Diabetes Product
Table 84. Novartis Recent Developments/Updates
Table 85. Huadong Medicine Corporation Information
Table 86. Huadong Medicine Description and Business Overview
Table 87. Huadong Medicine Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Huadong Medicine Oral Medicines for Diabetes Product
Table 89. Huadong Medicine Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Sanofi Oral Medicines for Diabetes Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Novo Nordisk Corporation Information
Table 96. Novo Nordisk Description and Business Overview
Table 97. Novo Nordisk Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Novo Nordisk Oral Medicines for Diabetes Product
Table 99. Novo Nordisk Recent Developments/Updates
Table 100. Servier Corporation Information
Table 101. Servier Description and Business Overview
Table 102. Servier Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Servier Oral Medicines for Diabetes Product
Table 104. Servier Recent Developments/Updates
Table 105. Takeda Pharmaceutical Corporation Information
Table 106. Takeda Pharmaceutical Description and Business Overview
Table 107. Takeda Pharmaceutical Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Takeda Pharmaceutical Oral Medicines for Diabetes Product
Table 109. Takeda Pharmaceutical Recent Developments/Updates
Table 110. Luye Pharmaceutical Corporation Information
Table 111. Luye Pharmaceutical Description and Business Overview
Table 112. Luye Pharmaceutical Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Luye Pharmaceutical Oral Medicines for Diabetes Product
Table 114. Luye Pharmaceutical Recent Developments/Updates
Table 115. Taiji Group Corporation Information
Table 116. Taiji Group Description and Business Overview
Table 117. Taiji Group Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Taiji Group Oral Medicines for Diabetes Product
Table 119. Taiji Group Recent Developments/Updates
Table 120. CR Double-Crane Corporation Information
Table 121. CR Double-Crane Description and Business Overview
Table 122. CR Double-Crane Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. CR Double-Crane Oral Medicines for Diabetes Product
Table 124. CR Double-Crane Recent Developments/Updates
Table 125. AstraZeneca Corporation Information
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. AstraZeneca Oral Medicines for Diabetes Product
Table 129. AstraZeneca Recent Developments/Updates
Table 130. Boehringer Ingelheim Corporation Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Boehringer Ingelheim Oral Medicines for Diabetes Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. Qilu Pharmaceutical Corporation Information
Table 136. Qilu Pharmaceutical Description and Business Overview
Table 137. Qilu Pharmaceutical Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Qilu Pharmaceutical Oral Medicines for Diabetes Product
Table 139. Qilu Pharmaceutical Recent Developments/Updates
Table 140. Jiangsu Deyuan Pharmaceutical Corporation Information
Table 141. Jiangsu Deyuan Pharmaceutical Description and Business Overview
Table 142. Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Product
Table 144. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 145. CTTQ Corporation Information
Table 146. CTTQ Description and Business Overview
Table 147. CTTQ Oral Medicines for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. CTTQ Oral Medicines for Diabetes Product
Table 149. CTTQ Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Oral Medicines for Diabetes Distributors List
Table 153. Oral Medicines for Diabetes Customers List
Table 154. Oral Medicines for Diabetes Market Trends
Table 155. Oral Medicines for Diabetes Market Drivers
Table 156. Oral Medicines for Diabetes Market Challenges
Table 157. Oral Medicines for Diabetes Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Medicines for Diabetes
Figure 2. Global Oral Medicines for Diabetes Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Oral Medicines for Diabetes Market Share by Type in 2022 & 2034
Figure 4. Biguanides Product Picture
Figure 5. Sulfonylureas Product Picture
Figure 6. Meglitinides Product Picture
Figure 7. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Picture
Figure 8. SGLT2 Inhibitors Product Picture
Figure 9. Thiazolidinediones Product Picture
Figure 10. Alpha-Glucosidase Inhibitors Product Picture
Figure 11. Other Product Picture
Figure 12. Global Oral Medicines for Diabetes Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 13. Global Oral Medicines for Diabetes Market Share by Application in 2022 & 2034
Figure 14. Hospital
Figure 15. Clinic
Figure 16. Other
Figure 17. Global Oral Medicines for Diabetes Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 18. Global Oral Medicines for Diabetes Market Size (2024-2034) & (US$ Million)
Figure 19. Global Oral Medicines for Diabetes Sales (2024-2034) & (K Units)
Figure 20. Global Oral Medicines for Diabetes Average Price (US$/Unit) & (2024-2034)
Figure 21. Oral Medicines for Diabetes Report Years Considered
Figure 22. Oral Medicines for Diabetes Sales Share by Manufacturers in 2022
Figure 23. Global Oral Medicines for Diabetes Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Oral Medicines for Diabetes Players: Market Share by Revenue in 2022
Figure 25. Oral Medicines for Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 26. Global Oral Medicines for Diabetes Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 27. North America Oral Medicines for Diabetes Sales Market Share by Country (2024-2034)
Figure 28. North America Oral Medicines for Diabetes Revenue Market Share by Country (2024-2034)
Figure 29. United States Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Canada Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Europe Oral Medicines for Diabetes Sales Market Share by Country (2024-2034)
Figure 32. Europe Oral Medicines for Diabetes Revenue Market Share by Country (2024-2034)
Figure 33. Germany Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. France Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. U.K. Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Italy Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Russia Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Asia Pacific Oral Medicines for Diabetes Sales Market Share by Region (2024-2034)
Figure 39. Asia Pacific Oral Medicines for Diabetes Revenue Market Share by Region (2024-2034)
Figure 40. China Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Japan Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. South Korea Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. India Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Australia Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. China Taiwan Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Latin America Oral Medicines for Diabetes Sales Market Share by Country (2024-2034)
Figure 48. Latin America Oral Medicines for Diabetes Revenue Market Share by Country (2024-2034)
Figure 49. Mexico Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Brazil Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Argentina Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Oral Medicines for Diabetes Sales Market Share by Country (2024-2034)
Figure 53. Middle East & Africa Oral Medicines for Diabetes Revenue Market Share by Country (2024-2034)
Figure 54. Turkey Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 56. UAE Oral Medicines for Diabetes Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Oral Medicines for Diabetes by Type (2024-2034)
Figure 58. Global Revenue Market Share of Oral Medicines for Diabetes by Type (2024-2034)
Figure 59. Global Oral Medicines for Diabetes Price (US$/Unit) by Type (2024-2034)
Figure 60. Global Sales Market Share of Oral Medicines for Diabetes by Application (2024-2034)
Figure 61. Global Revenue Market Share of Oral Medicines for Diabetes by Application (2024-2034)
Figure 62. Global Oral Medicines for Diabetes Price (US$/Unit) by Application (2024-2034)
Figure 63. Oral Medicines for Diabetes Value Chain
Figure 64. Oral Medicines for Diabetes Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed